Atypical properties of several classes of antipsychotic drugs on the basis of differential induction of Fos-like immunoreactivity in the rat brain

Life Sciences

Volumn 76, Issue 2, 2004, Pages 225-237

  Oka, Takuro ^a   Hamamura, Takashi ^a   Lee, Youmei ^b   Miyata, Shinji ^a   Habara, Toshiaki ^c   Endo, Shiro ^a   Taoka, Hideki ^a   Kuroda, Shigetoshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Mannari Hospital   (Japan)

^c Zikei Hospital   (Japan)

Author keywords

Antipsychotic drugs; Atypicality; c fos; Immediate early gene; Immunohistochemistry

Indexed keywords

BLONANSERIN; BROMPERIDOL; CARPIPRAMINE; CHLORPROMAZINE; CLOCAPRAMINE; CLOSPIPRAMINE; CLOZAPINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; EMONAPRIDE; FLUPHENAZINE; HALOPERIDOL; LEVOMEPROMAZINE; MOPERONE; NEUROLEPTIC AGENT; OLANZAPINE; OXYPERTINE; PERICIAZINE; PEROSPIRONE; PERPHENAZINE; PIMOZIDE; PIPAMPERONE; QUETIAPINE; RISPERIDONE; SEROTONIN 2A ANTAGONIST; SPIPERONE; SULPIRIDE; SULTOPRIDE; THIORIDAZINE; TIMIPERONE; ZOTEPINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NONHUMAN; RAT;

ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN; CELL NUCLEUS; CORPUS STRIATUM; INJECTIONS, SUBCUTANEOUS; MALE; NEURONS; NUCLEUS ACCUMBENS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR;

EID: 7044231508     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.08.009     Document Type: Article

References (41)

1. M.B. Assie, C. Cosi, and W. Koek 5-HT1A receptor agonist properties of the antipsychotic, nemonapride: Comparison with bromerguride and clozapine European Journal of Pharmacology 334 2-3 1997 141 147
2. R.M. Carelli, and M.O. West Representation of the body by single neurons in the dorsolateral striatum of the awake, unrestrained rat The Journal of Comparative Neurology 309 2 1991 231 249
3. C.L. Christoffersen, and L.T. Meltzer Reversal of haloperidol-induced extrapyramidal side effects in cebus monkeys by 8-hydroxy-2-(di-n-propylamino) tetralin and its enantiomers Neuropsychopharmacology 18 5 1998 399 402
4. A.Y. Deutch, M.C. Lee, and M.J. Iadarola Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action Molecular and Cellular Neurosciences 3 1992 332 341
5. M. Dragunow, and R. Faull The use of c-fos as a metabolic marker in neuronal pathway tracing Journal of Neuroscience Methods 29 3 1989 261 265
6. M. Dragunow, G.S. Robertson, R.L.M. Faull, H.A. Robertson, and K. Jansen D2 dopamine receptor antagonists induce Fos and related proteins in rat striatal neurons Neuroscience 37 2 1990 287 294
7. A. Fink-Jensen, and P. Kristensen Effects of typical and atypical neuroleptics on Fos protein expression in the rat forebrain Neuroscience Letters 182 1 1994 115 118
8. Y.G. Gelders, S.L.E. Heylen, G. Vanden Bussche, A.J.M. Reyntjens, and P.A.J. Janssen Pilot clinical investigation of risperidone in the treatment of psychotic patients Pharmacopsychiatry 23 5 1990 206 211
9. P.B. Hicks The effect of serotonergic agents on haloperidol-induced catalepsy Life Sciences 47 18 1990 1609 1615
10. A. Hirose, T. Kato, Y. Ohno, H. Shimizu, H. Tanaka, M. Nakamura, and J. Katsube Pharmacological actions of SM-9018, a new neuroleptic drug with both potent 5-hydroxytryptamine2 and dopamine2 antagonistic actions Japanese Journal of Pharmacology 53 3 1990 321 329
11. A. Inagaki, T. Inada, T. Fujii, and K. Yagi Dose equivalence of psychotropic drugs. Part IV: Dose equivalence of orally administered neuroleptics (4) Japanese Journal of Clinical Psychopharmacology 1 4 1998 443 448 (in Japanese)
12. R.W. Invernizzi, L. Cervo, and R. Samanin 8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin 1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis Neuropharmacology 27 5 1998 515 518
13. T. Ishibashi, R. Tagashira, M. Nakamura, H. Noguchi, and Y. Ohno Effects of perospirone, a novel 5-HT2 and D2 receptor antagonist, on Fos protein expression in the rat forebrain Pharmacology, Biochemistry, and Behavior 63 4 1999 535 541
14. S. Kapur, and P. Seeman Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications of atypical antipsychotic action Journal of Psychiatry and Neuroscience 25 2 2000 161 166
15. S. Kapur, and P. Seeman Dose fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics? A new hypothesis American Journal of Psychiatry 158 3 2001 360 369
16. T. Kato, A. Hirose, Y. Ohno, H. Shimizu, H. Tanaka, and M. Nakamura Binding profile of SM-9018, a novel antipsychotic candidate Japanese Journal of Pharmacology 54 4 1990 478 481
17. J.E. Leysen, W. Gommeren, A. Eens, D. de Chaffoy de Courcelles, J.C. Stoof, and P.A.J. Janssen Biochemical profile of risperidone, a new antipsychotic The Journal of Pharmacology and Experimental Therapeutics 247 2 1988 661 670
18. J.E. Leysen, P.M.F. Janssen, A. Schotte, W.H. Luyten, and A.A. Megens Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: Role of 5HT2 receptors Psychopharmacology 112 1 Suppl 1993 S40 S54
19. G.A. MacGibbon, P.A. Lawlor, R. Bravo, and M. Dragunow Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and island of Calleja Brain Research. Molecular Brain Research 23 1-2 1994 21 32
20. H.Y. Meltzer, S. Matsubara, and J. Lee Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonine2 pKi values The Journal of Pharmacology and Experimental Therapeutics 251 1 1989 238 246
21. K.M. Merchant, and D.M. Dorsa Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics Proceedings of National Academy of Sciences of United States of America 90 8 1993 3447 3451
22. J. Miller Induction of c-fos mRNA expression in rat striatum by neuroleptic drugs Journal of Neurochemistry 54 4 1990 1453 1455
23. J.T. Morgan, and T. Curran Stimulua-transcription coupling in the nervous system: Involvement of inducible proto-oncogens fos and jun Annual Review of Neuroscience 14 1991 421 451
24. T. Nakajima, J.L. Daval, P.F. Morgan, R.M. Post, and P.J. Marangos Adenosinergic modulation of caffeine-induced c-fos mRNA expression in mouse brain Brain Research 501 2 1989 307 314
25. T.V. Nguyen, B.E. Kosofsky, R. Birnbaum, B.M. Cohen, and S.E. Hyman Differential expression of c-fos and Zif 268 in rat striatum after haloperidol, clozapine and amphetamine Proceedings of National Academy of Sciences of United States of America 89 10 1992 4270 4274
26. Y. Noda, S. Kurumiya, Y. Miura, and M. Oka Comparative study of 2-(4-ethyl-1-piperazinyl)-4-(fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b] pyridine (AD-5423) and haloperidol for their pharmacological activities related to antipsychotic efficacy and/or adverse side-effects The Journal of Pharmacology and Experimental Therapeutics 265 2 1993 745 751
27. M. Oka, Y. Noda, Y. Ochi, K. Furukawa, T. Une, S. Kurumiya, K. Hino, and T. Karasawa Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties The Journal of Pharmacology and Experimental Therapeutics 264 1 1993 158 165
28. G. Palacino, M.A. Muro, and A. Paz Marin Differential effects of haloperidol and two anxiolytic drugs, buspirone and lesopitron, on c-Fos expression in the rat striatum and nucleus accumbens Brain Research 742 1-2 1996 141 148
29. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coodinates 4th ed. 1998 Academic Press Sydney
30. M. Pisa Motor functions of the striatum of the rat: critical role of the lateral region in tongue and forelimb reaching Neuroscience 24 2 1988 453 463
31. R.W. Preseley, D. Menetrey, J.D. Levine, and A.I. Basbaum Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord The Journal of Neuroscience 10 1 1990 323 335
32. G.S. Robertson, and H.C. Fibiger Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine Neuroscience 46 2 1992 315 328
33. G.S. Robertson, and H.C. Fibiger Effects of olanzapine on regional c-Fos expression in rat forebrain Neuropsychopharmacolgy 14 2 1996 105 110
34. G.S. Robertson, H. Matsumura, and H.C. Fibiger Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of antipsychotic activity The Journal of Pharmacology and Experimental Therapeutics 271 2 1994 1058 1066
35. S.M. Sagar, F.R. Sharp, and T. Curran Expression of c-fos protein in brain: Metabolic mapping at the cellular level Science 240 4857 1988 1328 1331
36. A. Schotte, P.F.M. Janssen, W. Gommeren, W.H.M.L. Luyten, P. Van Gompel, A.S. Lesage, K. De Loore, and J.E. Leysen Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding Pychopharmacology 124 1-2 1996 57 73
37. P. Seeman Atypical antipsychotics: mechanism of action Canadian Journal of Psychiatry 47 1 2002 27 38
38. J. Semba, M. Sakai, R. Miyoshi, N. Mataga, F. Fukamauchi, and S. Kito Differential expression of c-fos mRNA in rat prefrontal cortex, striatum, N. accumbens and lateral septum after typical and atypical antipsychotics: an in situ hybridization study Neurochemistry International 29 4 1996 435 442
39. S.Y. Shu, G. Ju, and L.Z. Fan The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system Neuroscience Letters 85 2 1988 169 171
40. P.O. Tremblay, J. Gervais, and C. Rouillard Modification of haloperidol-induced pattern of c-fos expression by serotonin agonists The European Journal of Neuroscience 10 11 1998 3546 3555
41. W. Wan, D.J. Ennulat, and B.M. Cohen Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain Brain Research 688 1-2 1995 95 104